Correlation Between GlaxoSmithKline PLC and Bellevue Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Bellevue Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Bellevue Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Bellevue Life Sciences, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Bellevue Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Bellevue Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Bellevue Life.

Diversification Opportunities for GlaxoSmithKline PLC and Bellevue Life

0.36
  Correlation Coefficient

Weak diversification

The 3 months correlation between GlaxoSmithKline and Bellevue is 0.36. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Bellevue Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bellevue Life Sciences and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Bellevue Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bellevue Life Sciences has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Bellevue Life go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Bellevue Life

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Bellevue Life. But the stock apears to be less risky and, when comparing its historical volatility, GlaxoSmithKline PLC ADR is 6.34 times less risky than Bellevue Life. The stock trades about -0.28 of its potential returns per unit of risk. The Bellevue Life Sciences is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  12.00  in Bellevue Life Sciences on August 26, 2024 and sell it today you would earn a total of  1.00  from holding Bellevue Life Sciences or generate 8.33% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy22.73%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Bellevue Life Sciences

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Bellevue Life Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Weak
Over the last 90 days Bellevue Life Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively abnormal fundamental indicators, Bellevue Life may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and Bellevue Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Bellevue Life

The main advantage of trading using opposite GlaxoSmithKline PLC and Bellevue Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Bellevue Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bellevue Life will offset losses from the drop in Bellevue Life's long position.
The idea behind GlaxoSmithKline PLC ADR and Bellevue Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios